86. Pulmonary arterial hypertension
1,083 clinical trials,   667 drugs   (DrugBank: 122 drugs),   98 drug target genes,   185 drug target pathways

Searched query = "Pulmonary arterial hypertension", "PAH", "IPAH", "HPAH", "Eisenmenger syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
4 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04266197
(ClinicalTrials.gov)
September 25, 202022/1/2020Effects of RT234 on Exercise Parameters Accessed by CPET in Subjects With PAHA Phase 2, Open-label, Single Dose Study to Evaluated the Safety and Efficacy of RT234 on Exercise Parameters Assessed by Cardiopulmonary Exercise Testing (CPET) in Subjects With Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial HypertensionCombination Product: Drug: RT234 - vardenafil inhalation powder; Device: Axially Oscillating Sphere dry powder inhaler (AOS DPI)Respira Therapeutics, Inc.Argint International;Precision For MedicineRecruiting18 Years80 YearsAll20Phase 2Serbia
2NCT01649739
(ClinicalTrials.gov)
September 201222/7/2012Vardenafil as add-on Therapy for Patients With Pulmonary Hypertension Treated With Inhaled IloprostPulmonary Arterial HypertensionDrug: LevitraRabin Medical CenterNULLNot yet recruiting18 Years70 YearsBoth20Phase 4Israel
3NCT00705588
(ClinicalTrials.gov)
August 200825/6/2008Long Acting Phosphodiesterase 5 Inhibitors as Add-on Therapy for Patients With Pulmonary Hypertension Treated With Prostanoids.Pulmonary Arterial HypertensionDrug: Tadalafil;Drug: VardenafilRabin Medical CenterNULLNot yet recruiting18 YearsN/ABoth30Phase 4Israel
4NCT00718952
(ClinicalTrials.gov)
July 200818/7/2008The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial HypertensionMulti-centre, Prospective, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Treatment of Pulmonary Arterial Hypertension With Vardenafil in ChinaPulmonary HypertensionDrug: Vardenafil;Drug: PlaceboTongji UniversityNULLCompleted12 Years65 YearsBoth60Phase 3China